Literature DB >> 3335984

Familial neonatal hemochromatosis with survival.

R B Colletti1, J J Clemmons.   

Abstract

We report two sisters with neonatal hemochromatosis (NHC), including the first documented survivor. Characterized by excessive parenchymal iron in liver, pancreas, heart, and other organs, but little iron in the spleen, bone marrow, or other sites of the reticuloendothelial system, NHC is rarely reported and has been uniformly fatal. The first infant (case 1) presented with neonatal hypoglycemia, coagulopathy, and mild hyperbilirubinemia; she rapidly deteriorated and died of multisystem failure. Autopsy showed cirrhosis. Her sister (case 2) presented similarly; liver biopsy showed giant cell hepatitis, which is consistent with idiopathic neonatal hepatitis (INHP). However, iron staining revealed that case 1 had extensive iron deposits in the liver, pancreas, heart, thymus, and bone, but none in bone marrow or spleen. Case 2 had grade 4 liver iron staining, normal bone marrow iron, elevated serum ferritin and transferrin saturation, and HLA-A3 haplotype. At 16 months of age, the growth, development, and serum measures of iron status in case 2 were normal; liver biopsy showed fibrosis, negative iron staining, and normal tissue iron concentration. NHC is compatible with survival, has clinicopathologic features that overlap with INHP, and may frequently be misdiagnosed as INHP. A prospective study is needed to determine the incidence and natural history of NHC--a disorder that may be more common than is currently recognized.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335984     DOI: 10.1097/00005176-198801000-00009

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

1.  Identification of neonatal liver failure and perinatal hemochromatosis in Canada.

Authors:  R Jackson; E A Roberts
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

2.  Neonatal hemochromatosis. The regulation of transferrin-receptor and ferritin synthesis by iron in cultured fibroblastic-line cells.

Authors:  A S Knisely; J B Harford; R D Klausner; S R Taylor
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers.

Authors:  A Verloes; I K Temple; A F Hubert; P Hope; S Gould; C Debauche; G Verellen; J L Deville; L Koulischer; E M Sokal
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

4.  Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism.

Authors:  A L Kelly; P W Lunt; F Rodrigues; P J Berry; D M Flynn; P J McKiernan; D A Kelly; G Mieli-Vergani; T M Cox
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

5.  Progress in treatment and outcome for children with neonatal haemochromatosis.

Authors:  D M Flynn; N Mohan; P McKiernan; S Beath; J Buckels; D Mayer; D A Kelly
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

6.  Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease.

Authors:  M M Silver; L S Valberg; E Cutz; L D Lines; M J Phillips
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 7.  New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients.

Authors:  Dominique Debray; Nadya Yousef; Philippe Durand
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

8.  Neonatal hemochromatosis. Genetic analysis of transferrin-receptor, H-apoferritin, and L-apoferritin loci and of the human leukocyte antigen class I region.

Authors:  L Hardy; J L Hansen; J P Kushner; A S Knisely
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.